Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression Academic Article uri icon

Overview

MeSH Major

  • Immunosuppressive Agents
  • Neoplasms
  • Tacrolimus
  • Transforming Growth Factor beta

abstract

  • Tacrolimus has a dose-dependent effect on tumor progression and TGF-beta(1) expression, and tacrolimus-induced TGF-beta(1) overexpression may be a pathogenetic mechanism in tumor progression.

publication date

  • August 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.TP.0000081399.75231.3B

PubMed ID

  • 12923450

Additional Document Info

start page

  • 597

end page

  • 602

volume

  • 76

number

  • 3